Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Skin Cancer Face × Dermatologic × Clear all

Status

Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 95 Lymphoma, T-Cell, Cutaneous 23 Mycosis Fungoides 18 Skin Neoplasms 17 Sezary Syndrome 16 Lymphoma, Non-Hodgkin 13 Lymphoma, Follicular 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Neoplasm Metastasis 10 Lymphoma, Mantle-Cell 10 Lymphoma, Large-Cell, Immunoblastic 10 Lymphoma, Large-Cell, Anaplastic 10 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, B-Cell, Marginal Zone 10 Lymphoma 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Burkitt Lymphoma 10 Hodgkin Disease 9 Carcinoma, Basal Cell 9 Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Keratosis, Actinic 8 Immunoblastic Lymphadenopathy 8 Waldenstrom Macroglobulinemia 7 Uveal Melanoma 7 Lymphoma, Extranodal NK-T-Cell 7 Leukemia, Myeloid, Acute 7 Leukemia, Hairy Cell 7 Myeloproliferative Disorders 6 Lung Neoplasms 6

Interventions

Physical Examination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03382704 2026-01-16

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

NHS Lothian

Skin Cancer Face

Data powered by HemOnc (CC BY 4.0) Colophon ⚡